Skip to main content
SpringerLink
Log in

Intravenous administration of high doses of carboplatin in multimodal treatment of high grade gliomas: a phase II study

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The object of this study is to evaluate the efficacy of a high dose of carboplatin in 20 patients operated on for high grade glioma (Group A) compared with a matched control (Group B) treated with BCNU administered after radiotherapy. The toxicity profile has been evaluated during the therapy. The survival of patients entering this study was measured in terms of months: the mean survival time was 10.45 months and the median 11.0 months in the — group treated with carboplatin (8 patients are still alive); the 18-month survival rate was 10%. The mean survival time of the control group was 9.85 months and the median 10.5 months; no patients are still alive and the 18-month survival rate was 0%. On the basis of our phase II clinical study, we could conclude that i.v. administration of high-doses of carboplatin in high grade gliomas is generally well tolerated and the results are better than those of a matched control treated with 1–2 courses of BCNU (low-dose). The adjuvant treatment and the role of carboplatin in the therapy of high grade gliomas is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aida T, Bodell WJ (1987) Cellular resistance to chlorethylnitro-soureas, nitrogen mustard and cis-diamrninedichloroplatinum II) in human glial-derived cell lines. Cancer Res 47: 1361–1366

    PubMed  Google Scholar 

  2. Brufman G, Halpern J, Sukes R, Catane R, Biran S (1984) Procarbazine, CCNU, and vincristine combination chemotherapy for brain tumours. Oncology 41: 239–241

    PubMed  Google Scholar 

  3. Cianfriglia F, Pompili A, Riccio A, Grassi A (1980) CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme. Cancer 45: 1289–1299

    PubMed  Google Scholar 

  4. Doy F, Berens ME, Dougherty DV, Rosenblum ML (1991) Comparison of the cytotoxic activities of cisplatin and carboplatin against gliomas cell lines at pharmalogically relevant drug exposure. J Neurooncol 11: 27–35

    PubMed  Google Scholar 

  5. EORTC Brain Tumor Group (1978) Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma-final evaluation. Eur J Cancer 14: 851–856

    Google Scholar 

  6. EORTC Brain Tumor Group (1985) Evaluation of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(l-aziridinyl)-3,6-dioxodiethylester) in recurring supratentorial malignant brain gliomas — a phase II study. Eur J Cancer Clin Oncol 21: 143–146

    Google Scholar 

  7. EORTC Brain Tumor Group (1981) Evaluation of CCNU, VM26, plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J Neurosurg 55: 27–31

    Google Scholar 

  8. Hochberg FD, Pruitt AA, Beck DO, DeBrun G, Davis K (1985) The rationale and the methodology for intra-arterial chemotherapy with BCNU as a treatment for glioblastoma. J Neurosurg 63: 876–880

    PubMed  Google Scholar 

  9. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457–481

    Google Scholar 

  10. Kornblith P, Walker M (1988) Chemotherapy for malignant gliomas. J Neurosurg 68: 1–17

    PubMed  Google Scholar 

  11. Kumar ARV, Renaudin J, Wilson CB, Bodrey EB, Enot KJ, Levin VA (1974) Procarbazine hydrochloridein the treatment of brain tumors. A phase II study. J Neurosurg 40: 365–371

    PubMed  Google Scholar 

  12. Levin A, Wilson CB, Davis R (1979) A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J Neurosurg 51: 526–532

    PubMed  Google Scholar 

  13. Mahaley MS, Hipp SW, Dropcho EJ, Bertsch L, Cush S, Tirey T, Gillespie GY (1989) Intracarotid cisplatin chemotherapy for recurrent glioma. J Neurosurg 70: 371–378

    PubMed  Google Scholar 

  14. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207–214

    PubMed  Google Scholar 

  15. Muggia FM (1989) Overview of carboplatin. Replasing, complementing and extending the therapeutic horizons of cisplatin. Semin Oncol 16 [Suppl 5]: 7–13

    PubMed  Google Scholar 

  16. Papavero L, Loew F, Jakche H (1987) Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Acta Neurochir (Wien) 85: 128–137

    Google Scholar 

  17. Poisson M, Pereon Y, Chiras J, Delattre JY (1991) Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA). J Neurooncol 10: 139–144

    PubMed  Google Scholar 

  18. Spence AM, Berger MS, Livingston RB (1992) Phase II evaluation of high dose intravenous cisplatin for the treatment of adult malignant gliomas recurrent after chloroethylnitrosurea failure. I Neurooncol 12: 187–191

    Google Scholar 

  19. Stewart DJ, O'Bryan RM, Al-Sarraf M (1983) Phase II study of cisplatin in recurrent astrocytomas in adults. A Southwest Oncology Group Study. J Neurooncol 1: 145–147

    PubMed  Google Scholar 

  20. Twelves CJ, Ash CM, Miles DW, Thomas DG, Souhami RL (1991) Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma. Cancer Chemother Pharmacol 27: 481–483

    PubMed  Google Scholar 

  21. Wagstaff A, Ward A, Benfield P, Heel RC (1989) Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs 37: 162–190

    PubMed  Google Scholar 

  22. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Hunt WE, MacCarty CS, Mahaley SM Jr, Mealey J Jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323–1329

    PubMed  Google Scholar 

  23. Walker WK, Mechtler L, Gleason MJ (1987) Intravenous carboplatin for recurrent glioma with carboplatin (CBDCA). Proc Am Soc Clin Oncol 6: 72

    Google Scholar 

  24. Warnick REet al (1994) A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol 19: 69–74

    PubMed  Google Scholar 

  25. World Health Organization (1979) Handbook for Reporting Results of Cancer Treatment. WHO Offset publication No. 48, Geneva

  26. Yung WK, Mechtler L, Gleason MJ (1991) Intravenous carboplatin for recurrent malignant glioma. A phase II study. J Clin Oncol 9: 860–864

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, University of Rome “La Sapienza”, 2nd Chair of Neurosurgery, Rome, Italy

    P. Lunardi, J. Osman Farah M.D., L. Mastronardi, F. Puzzilli & F. M. Lo Bianco

Authors
  1. P. Lunardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Osman Farah M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Mastronardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Puzzilli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. M. Lo Bianco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunardi, P., Osman Farah, J., Mastronardi, L. et al. Intravenous administration of high doses of carboplatin in multimodal treatment of high grade gliomas: a phase II study. Acta neurochir 138, 215–220 (1996). https://doi.org/10.1007/BF01411364

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01411364

Keywords

Search

Navigation